Home
TCBP
TCBP News

Latest TC BioPharm (Holdings) plc (TCBP) News on November 18, 2024

TCBP Awarded Non-Dilutive Funding, ScaleReady's G-Rex® Grant

PR Newswire

6 days ago

TCBP Awarded Non-Dilutive Funding, ScaleReady's G-Rex® Grant

TCBP Provides Shareholder Update and Highlights Recent Milestone Achievements

PR Newswire

19 days ago

TCBP Provides Shareholder Update and Highlights Recent Milestone Achievements

MT Newswires

24 days ago

TC BioPharm Rejects Delisting Rumors, Confirms Nasdaq Listing Compliance

TCBP Responds to False Social Media Claim

PR Newswire

24 days ago

TCBP Responds to False Social Media Claim

TCBP Enters Research Planning Collaboration with Dr. Carlos Maluquer de Motes for Mpox Therapeutic

PR Newswire

a month ago

TCBP Enters Research Planning Collaboration with Dr. Carlos Maluquer de Motes for Mpox Therapeutic

TCBP Announces Artificial Intelligence Initiative with Partner Carnegie Mellon University for Donor Screening

PR Newswire

a month ago

TCBP Announces Artificial Intelligence Initiative with Partner Carnegie Mellon University for Donor Screening

TCBP Announces Site Opening of Guys and St. Thomas Hospital

PR Newswire

2 months ago

TCBP Announces Site Opening of Guys and St. Thomas Hospital

TCBP to Present at the 2024 ThinkEquity Conference in NYC

PR Newswire

2 months ago

TCBP to Present at the 2024 ThinkEquity Conference in NYC

/C O R R E C T I O N -- TC BioPharm/

PR Newswire

2 months ago

/C O R R E C T I O N -- TC BioPharm/

TCBP Announces First Patient Completed the Full Fose Regimen in ACHIEVE Clinical Trial

PR Newswire

2 months ago

TCBP Announces First Patient Completed the Full Fose Regimen in ACHIEVE Clinical Trial

TC BioPharm Intends to Launch Preclinical Studies for Treatment of Monkey Pox

PR Newswire

2 months ago

TC BioPharm Intends to Launch Preclinical Studies for Treatment of Monkey Pox

MT Newswires

2 months ago

TC BioPharm Plans Preclinical Study of Potential Monkey Pox Treatment -- Shares Down After Hours

TC BioPharm Intends to Launch Preclinical Studies for Treatment of Monkey Pox

PR Newswire

2 months ago

TC BioPharm Intends to Launch Preclinical Studies for Treatment of Monkey Pox

TCBP Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference

PR Newswire

2 months ago

TCBP Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference

MT Newswires

2 months ago

Sector Update: Health Care Stocks Decline Late Afternoon

MT Newswires

2 months ago

Sector Update: Health Care

MT Newswires

2 months ago

Top Midday Gainers

TCBP Announces Dosing of 5 New Patients in ACHIEVE

PR Newswire

2 months ago

TCBP Announces Dosing of 5 New Patients in ACHIEVE

MT Newswires

3 months ago

Top Premarket Decliners

TC BioPharm secures European patent for cancer treatment

Pharmaceutical Technology

3 months ago

TC BioPharm secures European patent for cancer treatment

TC BioPharm Announces Closing of Upsized $6.0 Million Public Offering

PR Newswire

3 months ago

TC BioPharm Announces Closing of Upsized $6.0 Million Public Offering

TC BioPharm Announces Grant of European Patent Covering Use of Modified Gamma Delta Cells for the Treatment of Cancer and Viral Indications

PR Newswire

3 months ago

TC BioPharm Announces Grant of European Patent Covering Use of Modified Gamma Delta Cells for the Treatment of Cancer and Viral Indications

MT Newswires

3 months ago

TC BioPharm Regains Compliance With Nasdaq Listing Rules

TC BioPharm Regains Compliance with Nasdaq Listing Rule 5550(b)

PR Newswire

3 months ago

TC BioPharm Regains Compliance with Nasdaq Listing Rule 5550(b)

TC BioPharm Announces Closing of $2.0 Million Public Offering

PR Newswire

3 months ago

TC BioPharm Announces Closing of $2.0 Million Public Offering

MT Newswires

3 months ago

Top Premarket Decliners

TC BioPharm Announces Pricing of $2.0 Registered Direct Offering

PR Newswire

3 months ago

TC BioPharm Announces Pricing of $2.0 Registered Direct Offering

TCBP Announces Plan to Implement ADS Ratio Change

PR Newswire

4 months ago

TCBP Announces Plan to Implement ADS Ratio Change

MT Newswires

4 months ago

TC BioPharm Doses Sixth Person in TCB-008 Trial for Acute Myeloid Leukemia Treatment

TCBP Announces Dosing of 6th Patient in ACHIEVE Study in Patients with Acute Myeloid Leukemia

PR Newswire

4 months ago

TCBP Announces Dosing of 6th Patient in ACHIEVE Study in Patients with Acute Myeloid Leukemia

TCBP Announces Launch of Compassionate Use Program for TCB008

PR Newswire

6 months ago

TCBP Announces Launch of Compassionate Use Program for TCB008

TC BioPharm Announces Exercise of Warrants for £3.1 Million Gross Proceeds

PR Newswire

6 months ago

TC BioPharm Announces Exercise of Warrants for £3.1 Million Gross Proceeds

TC BioPharm Announces Execution of Second Non-Binding Letter of Intent for Acquisition, Targeting Innovative CAR-T Therapies

PR Newswire

6 months ago

TC BioPharm Announces Execution of Second Non-Binding Letter of Intent for Acquisition, Targeting Innovative CAR-T Therapies

TCBP Announces Execution of Non-Binding Letter of Intent for Acquisition of NK Platform Technologies

PR Newswire

7 months ago

TCBP Announces Execution of Non-Binding Letter of Intent for Acquisition of NK Platform Technologies

TCBP Increasing Treatment Capacity with Expanded Manufacturing Process

PR Newswire

8 months ago

TCBP Increasing Treatment Capacity with Expanded Manufacturing Process

TCBP Adjourns General Meeting Until a Later Date

PR Newswire

8 months ago

TCBP Adjourns General Meeting Until a Later Date

TCBP Announces Exercise of Series D Warrants For Cash

PR Newswire

8 months ago

TCBP Announces Exercise of Series D Warrants For Cash

Bryan Kobel, CEO of TCBP, Appears on Nationally Syndicated "The Big Biz Show"

PR Newswire

9 months ago

Bryan Kobel, CEO of TCBP, Appears on Nationally Syndicated "The Big Biz Show"

TCBP Announces Shareholder Update Call on March 5th 2024

PR Newswire

9 months ago

TCBP Announces Shareholder Update Call on March 5th 2024

TCBP Announces MHRA Acceptance of Amendment for ACHIEVE UK Trial

PR Newswire

9 months ago

TCBP Announces MHRA Acceptance of Amendment for ACHIEVE UK Trial

TC BioPharm Management to Participate at Upcoming 7th CAR-TCR Summit Europe

PR Newswire

9 months ago

TC BioPharm Management to Participate at Upcoming 7th CAR-TCR Summit Europe

TCBP Provides Shareholder Update and Highlights Upcoming Milestones

PR Newswire

9 months ago

TCBP Provides Shareholder Update and Highlights Upcoming Milestones

Argus Research

10 months ago

Daily – Vickers Top Insider Picks for 02/02/2024

NightHawk Receives Proceeds of $3.25 Million in Connection with Sale of Non-Core Intellectual Property and Issuance of a Low Interest Bearing Note

GlobeNewswire

10 months ago

NightHawk Receives Proceeds of $3.25 Million in Connection with Sale of Non-Core Intellectual Property and Issuance of a Low Interest Bearing Note

Vuzix Establishes Ophthalmic Advisory Board to Better Serve Human Vision Correction Needs with AR Glasses

PR Newswire

10 months ago

Vuzix Establishes Ophthalmic Advisory Board to Better Serve Human Vision Correction Needs with AR Glasses

TC BioPharm Chief Executive Officer, Bryan Kobel Featured on 'The Big Biz Show'

PR Newswire

10 months ago

TC BioPharm Chief Executive Officer, Bryan Kobel Featured on 'The Big Biz Show'

ElectraMeccanica and Xos Host Joint Investor Call to Provide Shareholder Update

GlobeNewswire

10 months ago

ElectraMeccanica and Xos Host Joint Investor Call to Provide Shareholder Update

NEXGEL to Present at The Microcap Conference, January 30th through February 1st

GlobeNewswire

10 months ago

NEXGEL to Present at The Microcap Conference, January 30th through February 1st

TC BioPharm to Present at the Sequire Investor Summit

PR Newswire

10 months ago

TC BioPharm to Present at the Sequire Investor Summit

CENTOGENE Announces Preliminary Full Year 2023 Revenue

GlobeNewswire

10 months ago

CENTOGENE Announces Preliminary Full Year 2023 Revenue

Nukkleus Signs MOU to Substantially Increase Holdings in Jacobi Asset Management

Business Wire

10 months ago

Nukkleus Signs MOU to Substantially Increase Holdings in Jacobi Asset Management

Syra Health to Participate in Lytham Partners 2024 Investor Select Conference

PR Newswire

10 months ago

Syra Health to Participate in Lytham Partners 2024 Investor Select Conference

Billy Joel Ticket Prices Surge Before Slate of One Night Only Shows

GlobeNewswire

10 months ago

Billy Joel Ticket Prices Surge Before Slate of One Night Only Shows

TC BioPharm Regains Compliance with Nasdaq Minimum Bid Price Requirement

PR Newswire

10 months ago

TC BioPharm Regains Compliance with Nasdaq Minimum Bid Price Requirement

Safe Harbor Financial Originates $9 Million First Lien Secured Loan for Major, MSO-Operated Cultivation Facility in Denver, Colorado

GlobeNewswire

10 months ago

Safe Harbor Financial Originates $9 Million First Lien Secured Loan for Major, MSO-Operated Cultivation Facility in Denver, Colorado

Eco Wave Power Commences Sending of Clean Electricity to the Israeli National Electrical Grid

PR Newswire

10 months ago

Eco Wave Power Commences Sending of Clean Electricity to the Israeli National Electrical Grid

TC BioPharm Announces Additional Cost Reduction Steps to Improve Financial Standing and Streamline Efficiencies

PR Newswire

10 months ago

TC BioPharm Announces Additional Cost Reduction Steps to Improve Financial Standing and Streamline Efficiencies

TC BioPharm Announces Closing of $3.5 Million Public Offering

PR Newswire

a year ago

TC BioPharm Announces Closing of $3.5 Million Public Offering

Jefferies initiates coverage on Chewy, other pet stocks

Yahoo Finance Video

a year ago

Jefferies initiates coverage on Chewy, other pet stocks

TC BioPharm Announces Pricing of $3.5 Million Public Offering

PR Newswire

a year ago

TC BioPharm Announces Pricing of $3.5 Million Public Offering

TC BioPharm Announces Formation of Commercial Development Division, Led by Industry Veteran, Dr. Lauren Bor Ph.D

PR Newswire

a year ago

TC BioPharm Announces Formation of Commercial Development Division, Led by Industry Veteran, Dr. Lauren Bor Ph.D

TC BioPharm Announces Plan to Implement ADS Ratio Change

PR Newswire

a year ago

TC BioPharm Announces Plan to Implement ADS Ratio Change

ArrowMark Financial Corp. Announces Special Distribution of $0.10 and Regular Cash Distribution of $0.45 per Share for the Fourth Quarter 2023

GlobeNewswire

a year ago

ArrowMark Financial Corp. Announces Special Distribution of $0.10 and Regular Cash Distribution of $0.45 per Share for the Fourth Quarter 2023

Webuy Global Limited Reports 62% Increase in Revenue to $24.4 Million for the First Half of 2023

GlobeNewswire

a year ago

Webuy Global Limited Reports 62% Increase in Revenue to $24.4 Million for the First Half of 2023

Business Wire

a year ago

Graphite for North America Graphex Group Receives Unsolicited Preliminary Offer and LOI to Buy Graphex Technologies and Propel its North American Expansion Strategy

We're A Little Worried About NeuroSense Therapeutics' (NASDAQ:NRSN) Cash Burn Rate

Simply Wall St.

a year ago

We're A Little Worried About NeuroSense Therapeutics' (NASDAQ:NRSN) Cash Burn Rate

Velo3D Sapphire Printers Become the First Metal 3D Printers to Achieve the U.S. Department of Defense’s Green-level STIG Compliance

Business Wire

a year ago

Velo3D Sapphire Printers Become the First Metal 3D Printers to Achieve the U.S. Department of Defense’s Green-level STIG Compliance

Zacks Small Cap Research

a year ago

AYRO: Two steps forward, one step back. Complex financing throws a wrench in our thesis.

Ayro, Inc. (NASDAQ:AYRO) Q3 2023 Earnings Call Transcript

Insider Monkey

a year ago

Ayro, Inc. (NASDAQ:AYRO) Q3 2023 Earnings Call Transcript

Will Pieris Pharmaceuticals (NASDAQ:PIRS) Spend Its Cash Wisely?

Simply Wall St.

a year ago

Will Pieris Pharmaceuticals (NASDAQ:PIRS) Spend Its Cash Wisely?

AstraZeneca's (AZN) Capivasertib Gets FDA Nod for Breast Cancer

Zacks

a year ago

AstraZeneca's (AZN) Capivasertib Gets FDA Nod for Breast Cancer

voxeljet AG Reports Financial Results for the Third Quarter Ended September 30, 2023

Business Wire

a year ago

voxeljet AG Reports Financial Results for the Third Quarter Ended September 30, 2023

GlobeNewswire

a year ago

Interactive Strength Inc. d/b/a FORME Reports Third Quarter 2023 Results

HeartBeam Reports Third Quarter 2023 Financial Results

Business Wire

a year ago

HeartBeam Reports Third Quarter 2023 Financial Results

Ideal Power Reports Third Quarter 2023 Financial Results

ACCESSWIRE

a year ago

Ideal Power Reports Third Quarter 2023 Financial Results

Zacks Small Cap Research

a year ago

CTSO: CytoSorbents reports 3rd quarter 2023 financial and operating results which showed strong product revenue growth and an improved cost structure.

Rocky Mountain Chocolate Appoints Kara Conklin as New Vice President of Franchise Development

GlobeNewswire

a year ago

Rocky Mountain Chocolate Appoints Kara Conklin as New Vice President of Franchise Development

Healthcare Triangle Reports Third Quarter 2023 Results

GlobeNewswire

a year ago

Healthcare Triangle Reports Third Quarter 2023 Results

Thomson Reuters StreetEvents

a year ago

Q3 2023 Cytosorbents Corp Earnings Call

Business Wire

a year ago

CuriosityStream Announces Third Quarter 2023 Financial Results

Thomson Reuters StreetEvents

a year ago

Q3 2023 Franklin Street Properties Corp Earnings Call

Associated Press Finance

a year ago

Franklin Street: Q3 Earnings Snapshot

Business Wire

a year ago

CuriosityStream To Report Third Quarter 2023 Financial Results on November 9, 2023

Yoshitsu Co., Ltd. Announces the Establishment of New Subsidiaries in the U.S.

GlobeNewswire

a year ago

Yoshitsu Co., Ltd. Announces the Establishment of New Subsidiaries in the U.S.

Thomson Reuters StreetEvents

a year ago

Q1 2024 Unifi Inc Earnings Call

Oak Valley Bancorp (NASDAQ:OVLY) shareholders have earned a 9.0% CAGR over the last five years

Simply Wall St.

a year ago

Oak Valley Bancorp (NASDAQ:OVLY) shareholders have earned a 9.0% CAGR over the last five years

Unifi Inc (UFI) Reports Q1 Fiscal 2024 Results: Net Sales Down by 22.7%

GuruFocus.com

a year ago

Unifi Inc (UFI) Reports Q1 Fiscal 2024 Results: Net Sales Down by 22.7%

Share on Social Networks: